Forecasting Magnitude and Frequency of Seasonal Streamflow Extremes Using a Bayesian Hierarchical Framework by Álvaro Ossandón, Balaji Rajagopalan, William Kleiber

Get full text

ROLE OF GENDER SPECIFICS IN MYOCARDIAL REMODELLING, CARDIOVASCULAR COMPLICATIONS DEVELOPMENT AND EFFICACY OF PHARMACOTHERAPY IN HEART FAILURE PATIENTS AFTER CARDIAC SURGERY by Yu. V. Liskova, А. А. Stadnikov, S. P. Salikova

“…In HFpEF males there was decrease of EF with transition to “grey zone” by III functional class, and eccentric remodeling predominated with unchanged diastolic function. …”
Get full text

Differential Effects of Landiolol in Patients with Atrial Fibrillation and Atrial Tachycardia by Kengo Ayabe, Tomoyoshi Komiyama, Hiroyuki Takekawa, Honsa Kang, Yasuaki Tsumagari, Miwa Ito, Keiichi Ashikaga, Yoshisato Shibata

“…To this end, we evaluated the efficacy and safety of landiolol in managing tachycardiac AF and tachycardiac atrial flutter/AT in 44 patients with reduced left ventricular function. We found that while landiolol was effective in managing patients with AF and heart failure with a preserved or mid-range ejection fraction, however, it might be more challenging to control heart rate in patients with AT using a similar dosage of landiolol.…”
Get full text

Efficacy of angiotensin receptor neprilysin inhibitor for maintenance hemodialysis patients with different types of left ventricular ejection fraction heart failure by Jin-cong Li, Nan-hui Zhang, Lei Wang, Jun-meng Peng, Hui-hui Wang, Wen-hui Chen

“…Methods From June 1, 2022 to May 31, 2023, 155 MHD patients with concurrent HF continuously taking S/V for more than 3 months were selected. According to the level of LVEF, they were assigned into three groups of HF with reduced ejection fraction（HFrEF, n=41）, HF with mid-range ejection fraction（HFmrEF, n=42） and HF with preserved ejection fraction（HFmrEF, n=2）. …”
Get full text